Who
Peter Diamandis
Director
Company insider
Files Form 4 as: Director, Celularity; Director, Vaxxinity; Director, DPCM Capital; Other, CuriosityStream; Director, 3D Systems; Director, Myos.
In numbers
- Trades disclosed
- 52
- Buys
- 2
- Sells
- 1
- Bought
- $50K
- Sold
- $3,224
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 15 Aug 2011
- Last trade
- 12 Jan 2026
- Last filed
- 15 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jan 2026filed 15 Jan 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —20,385 at $0.00 | filing |
| 12 Jan 2026filed 15 Jan 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —20,385 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —20,385 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —20,385 at $0.00 | filing |
| 29 Dec 2025filed 30 Dec 2025 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code A | —156,250 at $0.00 | filing |
| 29 Dec 2025filed 30 Dec 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 19 Dec 2025filed 22 Dec 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —67,416 at $0.00 | filing |
| 19 Nov 2025filed 21 Nov 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —47,042 at $0.00 | filing |
| 19 Dec 2024filed 3 Mar 2025 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code A | —84,746 at $0.00 | filing |
| 19 Dec 2024filed 3 Mar 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —67,416 at $0.00 | filing |
| 19 Dec 2024filed 6 Jan 2025 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code A | —84,746 at $0.00 | filing |
| 19 Dec 2024filed 6 Jan 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —67,416 at $0.00 | filing |
| 20 Jun 2023filed 26 Jun 2023 | Vaxxinityoption or derivative | SEC FORM 4 Code A | —132,352 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code A | —277,778 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —199,921 at $0.00 | filing |
| 26 Apr 2023filed 2 May 2023 | Vaxxinityoption or derivative | SEC FORM 4 Code M | —429,037 at $0.00 | filing |
| 26 Apr 2023filed 2 May 2023 | Vaxxinityoption or derivative | SEC FORM 4 Code M | —46,500 at $0.00 | filing |
| 26 Apr 2023filed 2 May 2023 | Vaxxinity | SEC FORM 4 Code M | $245K429,037 at $0.57 | filing |
| 26 Apr 2023filed 2 May 2023 | Vaxxinity | SEC FORM 4 Code M | $56K46,500 at $1.21 | filing |
| 10 Feb 2023filed 14 Feb 2023 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,071,000 at $0.00 | filing |
News
Why Peter Diamandis Thinks UAPs May Be Watching Nuclear Sites and the Rise of Artificial Superintelligenceibtimes.co.uk · 9 Sep 2026
1 headline in the last 90 days name Peter Diamandis; no company of theirs resolves to a name we track.